Am J Perinatol 2019; 36(S 02): S48-S53
DOI: 10.1055/s-0039-1691800
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The ReSVinet Score for Bronchiolitis: A Scale for All Seasons

Antonio José Justicia-Grande
1  GENVIP Group (Genética, Vacunas, Infecciones y Pediatría), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain
2  Translational Paediatrics and Infectious Diseases Unit, Department of Paediatrics. Hospital Clínico Universitario de Santiago de Compostela, A Coruña, Spain
,
Federico Martinón-Torres
1  GENVIP Group (Genética, Vacunas, Infecciones y Pediatría), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain
2  Translational Paediatrics and Infectious Diseases Unit, Department of Paediatrics. Hospital Clínico Universitario de Santiago de Compostela, A Coruña, Spain
› Author Affiliations
Funding FMT research activities are supported by Instituto de Salud Carlos III (Proyecto de Investigación en Salud, Acción Estratégica en Salud) project ReSVinext ISCIII/PI16/01569/Cofinanciado FEDER.
Further Information

Publication History

Publication Date:
25 June 2019 (online)

Abstract

The ReSVinet Scale is a clinical score for the assessment of respiratory difficulty in infancy. Our aim was to provide an update on the characteristics that make this tool different to any other. We descriptively compared the characteristics of the ReSVinet Scale with other options that can be found in the current literature or mobile apps stores. The ReSVinet Scale has been devised for its use regardless of the age of the child, entity causing respiratory symptoms, and setting. To this date, it is the only pediatric respiratory scale for acute respiratory distress that provides a parental version, and it is also the first one to have undergone validation in primary care. The tool can be found either in paper format or can be downloaded via App stores for devices running on Android or iOS systems. It has also been adopted recently as the assessment instrument for several clinical trials and for an IMI2 initiative (RESCEU project). All the aforementioned characteristics of the ReSVinet Scale should help toward its dissemination, as currently no other clinical tool for the assessment of respiratory difficulty can offer those advantages.

Ethical Approval

Investigations concerning the development and testing of the ReSVinet Scale were granted approval by the regional Ethics Committee in Galicia (registration number 2010/015). Written informed consent was gathered from all legal guardians prior to subject inclusion.